Spansules

Hyderabad, India Founded: 2000 • Age: 26 yrs
Pharmaceutical pellet manufacturing and formulation development in India.
Annual revenue $9.5M Latest available
Total funding - Funding intelligence
Employees 52 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Spansules

Spansules is a company based in Hyderabad (India) founded in 2000. The company has 52 employees as of March 26, 2025. Spansules offers products and services including Orlistat Pellets and Tamsulosin Pellets.

  • Headquarter Hyderabad, India
  • Employees 52 as on 26 Mar, 2025
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Social
    *********
  • Legal Name Spansules Pharmatech Private Limited
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $9.47 M (USD)
    1.84
    as on Mar 31, 2023
  • Net Profit
    $289.49 K (USD)
    14.85
    as on Mar 31, 2023
  • EBITDA
    $541.23 K (USD)
    25.91
    as on Mar 31, 2023
  • Latest Funding Round
  • Investors
  • Employee Count
    52

    as on Mar 26, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Spansules

Spansules offers a comprehensive portfolio of products and services, including Orlistat Pellets and Tamsulosin Pellets.

Primary

Orlistat pellets are produced for anti-obesity applications, with formulations that are customized for sustained release

Tamsulosin pellets are developed for anti-BPH treatments, focusing on sustained release to enhance drug efficacy

Funding Insights of Spansules

Investments & Acquisitions by Spansules

Investments

Financial Statements - Spansules

Spansules Comparisons

+
Add Comparison
Available on Premium

Competitors of Spansules

Latest news on Spansules

Frequently Asked Questions about Spansules

Spansules was founded in 2000.

Spansules is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

As of Mar 26, 2025, the latest employee count at Spansules is 52.

Annual revenue of Spansules is $9.47M as on Mar 31, 2023.

Spansules is identified as a pharmaceutical company that was established in 2000, with manufacturing and RD facilities dedicated to pellet production. It is recognized for adhering to WHO-GMP and ISO 9001:2015 standards, where products like Orlistat and Tamsulosin pellets are developed for sustained and delayed release. Contract-based customization and formulation services are provided, contributing to advancements in generic drugs. The companys operations are based in Hyderabad, India, focusing on quality and innovation in healthcare solutions. (72 words).

Spansules offers Orlistat Pellets and Tamsulosin Pellets.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available